knowledge -WSS

knowledge

author：Wikipedia 2025-10-01 19:41:35 - browse：2

Most everything is looking up for Orexo, the company reported on its second quarter earnings call on Tuesday. That is, everything but its digital therapies pipeline.

The Swedish pharmaceutical company, which makes almost all of its money from U.S. sales of its drug for opioid dependence, notched a number of important victories in the quarter: It successfully defended its patents in a case against Sun Pharmaceuticals, it resolved a packaging issue that was holding up the approval of its long-acting rescue medication, and it grew revenues for Zubsolv, its most important product. The company trimmed its losses to 12.6 million SEK, or $1.2 million, and executives reported that with fewer one-time expenses on the horizon, profitability was “in sight.”

“We are at an exciting turning point for the company and I hope our self confidence and optimism is something that you can share,” CEO Nikolaj Sørensen said on the company’s earnings call while cautioning that “there’s a lot more work to be done.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Medicare will require more price transparency from hospitals

WSS

3 killed, 8 injured in late

Free speech concerns arise in wake of journal editor Eisen's firing

Noem? Reynolds? A very early look at the Republican 'veepstakes'

Trump pressured former Arizona governor to overturn 2020 election results: Sources

US recommends Americans reconsider traveling to China due to arbitrary law enforcement, exit bans

Biotech incubator Curie.Bio graduates its first startup

focus

knowledge

leisure time

In Memoriam: Notable people who died in 2023

Churchill Downs extends trainer Bob Baffert's ban through 2024

At least 13 dead in Texas as scorching temps continue

Abortion clinic in Cancun will cater to Americans

Tori Bowie and the unacceptable rates of Black maternal death

The new shift in health care is toward less care

Dobbs anniversary: the lost opportunity of abortion as health care

Elon Musk announces 'temporary limits' for reading Twitter posts

The high cost of giving birth even with insurance

ThunderShirts, dance parties and anxiety meds can help ease dogs' July Fourth dread

leisure time

AstraZeneca CEO says participant had neurological symptoms, could be discharged today

Russians and Belarusians back at Wimbledon as war in Ukraine continues

Sanofi CEO defends move to abandon profit guidance, boost research

Greece's new parliament sworn in following conservative party's election victory

STAT Executive Editor Rick Berke on STAT's 8th birthday

Senate panel clears PBM, hopsital reforms

entertainment

explore

knowledge

knowledge